Cholesterol drug after emergency heart attack care
Part of Heart & circulation clinical trials.
This study tests whether adding bempedoic acid (a cholesterol-lowering pill) to standard care after a heart attack helps recovery and reduces inflammation. It may help lower your risk of future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have had a heart attack (called a STEMI).
- You must be having or have just had an emergency procedure to open a blocked artery (primary angioplasty).
- You must not be allergic to bempedoic acid (a cholesterol-lowering drug).
- You must not have an active infection, a chronic inflammatory condition, or severe liver or kidney problems.
- You must not be taking immune-suppressing drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a medication called bempedoic acid to standard cholesterol-lowering pills is better at lowering cholesterol after a heart attack. If you have recently had a heart attack and are already on statins, this might be an option to help prevent future heart problems.
This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
This study tests a new medicine called bempedoic acid that helps lower LDL (bad) cholesterol in people who are already on statins or other cholesterol treatments. It may offer an additional option for people who need to lower their cholesterol further because of heart disease risks.
This study compares a newer cholesterol-lowering medicine called bempedoic acid to statins in people who have trouble sticking with statins. It aims to see which treatment lowers LDL cholesterol more effectively and is easier to tolerate.
This study tests whether giving a strong cholesterol-lowering treatment right after a heart attack helps reduce the chance of future heart problems. It's for people who are not already on cholesterol medications.
Hear when a new ST Elevation (STEMI) Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.